Inhibition	O
of	O
Sebum	B:C0036511
Production	O
with	O
the	O
Acetyl	O
Coenzyme	I:C0001022
A	I:C0001022
Carboxylase	I:C0001022
Inhibitor	O
Olumacostat	O
Glasaretil	I:C1254351
.	O

Inhibition	O
of	O
Sebum	O
Production	O
with	O
the	O
Acetyl	B:C0001022
Coenzyme	I:C0001022
A	I:C0001022
Carboxylase	I:C0001022
Inhibitor	O
Olumacostat	O
Glasaretil	I:C1254351
.	O

Inhibition	O
of	O
Sebum	O
Production	O
with	O
the	O
Acetyl	O
Coenzyme	I:C0001022
A	I:C0001022
Carboxylase	I:C0001022
Inhibitor	O
Olumacostat	B:C1254351
Glasaretil	I:C1254351
.	O

Olumacostat	B:C1254351
glasaretil	I:C1254351
(	O
Olumacostat	O
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	O
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	O
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	O
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Olumacostat	O
glasaretil	I:C1254351
(	O
Olumacostat	B:C1254351
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	O
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	O
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	O
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Olumacostat	O
glasaretil	I:C1254351
(	O
Olumacostat	O
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	B:C0001022
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	O
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	O
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Olumacostat	O
glasaretil	I:C1254351
(	O
Olumacostat	O
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	O
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	B:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	O
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	O
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Olumacostat	O
glasaretil	I:C1254351
(	O
Olumacostat	O
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	O
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	B:C0014442
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	O
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Olumacostat	O
glasaretil	I:C1254351
(	O
Olumacostat	O
glasaretil	I:C1254351
)	O
is	O
a	O
small	O
molecule	O
inhibitor	O
of	O
acetyl	O
coenzyme	I:C0001022
A	I:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
(	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
)	O
,	O
the	O
enzyme	O
that	O
controls	O
the	O
first	O
rate	O
-	O
limiting	O
step	O
in	O
fatty	B:C0596562
acid	I:C0596562
biosynthesis	I:C0596562
.	O

Inhibition	O
of	O
ACC	B:C1150657
activity	I:C1150657
in	O
the	O
sebaceous	O
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	O
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	O
sebum	O
components	I:C0036511
contain	O
fatty	O
acids	I:C0015684
.	O

Inhibition	O
of	O
ACC	O
activity	I:C1150657
in	O
the	O
sebaceous	B:C0036505
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	O
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	O
sebum	O
components	I:C0036511
contain	O
fatty	O
acids	I:C0015684
.	O

Inhibition	O
of	O
ACC	O
activity	I:C1150657
in	O
the	O
sebaceous	O
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	B:C0036511
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	O
sebum	O
components	I:C0036511
contain	O
fatty	O
acids	I:C0015684
.	O

Inhibition	O
of	O
ACC	O
activity	I:C1150657
in	O
the	O
sebaceous	O
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	O
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	B:C0086418
sebum	O
components	I:C0036511
contain	O
fatty	O
acids	I:C0015684
.	O

Inhibition	O
of	O
ACC	O
activity	I:C1150657
in	O
the	O
sebaceous	O
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	O
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	O
sebum	B:C0036511
components	I:C0036511
contain	O
fatty	O
acids	I:C0015684
.	O

Inhibition	O
of	O
ACC	O
activity	I:C1150657
in	O
the	O
sebaceous	O
glands	I:C0036505
is	O
designed	O
to	O
substantially	O
affect	O
sebum	O
production	O
,	O
because	O
over	O
80	O
%	O
of	O
human	O
sebum	O
components	I:C0036511
contain	O
fatty	B:C0015684
acids	I:C0015684
.	O

Olumacostat	B:C1254351
glasaretil	I:C1254351
inhibits	O
de	O
novo	O
lipid	O
synthesis	I:C1563744
in	O
primary	O
and	O
transformed	O
human	O
sebocytes	O
.	O

Olumacostat	O
glasaretil	I:C1254351
inhibits	O
de	O
novo	O
lipid	B:C1563744
synthesis	I:C1563744
in	O
primary	O
and	O
transformed	O
human	O
sebocytes	O
.	O

Olumacostat	O
glasaretil	I:C1254351
inhibits	O
de	O
novo	O
lipid	O
synthesis	I:C1563744
in	O
primary	O
and	O
transformed	O
human	B:C0086418
sebocytes	O
.	O

Olumacostat	O
glasaretil	I:C1254351
inhibits	O
de	O
novo	O
lipid	O
synthesis	I:C1563744
in	O
primary	O
and	O
transformed	O
human	O
sebocytes	B:C1710037
.	O

TrueMass	B:C0936012
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	B:C0443609
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	B:C0015687
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	B:C0023779
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	B:C0012262
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	B:C0041004
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	B:C0031676
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	B:C0008387
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	B:C0014898
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	B:C1254351
glasaretil	I:C1254351
-	O
treated	O
sebocytes	O
.	O

TrueMass	O
Sebum	I:C0936012
Panel	I:C0936012
analyses	I:C0936012
showed	O
a	O
reduction	O
in	O
saturated	O
and	O
monounsaturated	O
fatty	I:C0015687
acyl	I:C0015687
chains	I:C0015687
across	O
lipid	O
species	I:C0023779
,	O
including	O
di-	O
and	O
triacylglycerols	O
,	O
phospholipids	O
,	O
cholesteryl	O
esters	I:C0008387
,	O
and	O
wax	O
esters	I:C0014898
in	O
Olumacostat	O
glasaretil	I:C1254351
-	O
treated	O
sebocytes	B:C1710037
.	O

There	O
was	O
no	O
shift	O
to	O
shorter	O
acyl	O
chain	O
lengths	O
observed	O
,	O
suggesting	O
that	O
the	O
fatty	B:C0015684
acid	I:C0015684
chain	O
elongation	O
process	O
was	O
not	O
affected	O
.	O

There	O
was	O
no	O
shift	O
to	O
shorter	O
acyl	O
chain	O
lengths	O
observed	O
,	O
suggesting	O
that	O
the	O
fatty	O
acid	I:C0015684
chain	O
elongation	O
process	O
was	O
not	B:C1513916
affected	O
.	O

Olumacostat	B:C1254351
glasaretil	I:C1254351
is	O
a	O
pro-drug	O
of	O
the	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibitor	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
and	O
was	O
designed	O
to	O
enhance	O
delivery	O
in	O
vivo	I:C1515655
.	O

Olumacostat	O
glasaretil	I:C1254351
is	O
a	O
pro-drug	B:C0033262
of	O
the	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibitor	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
and	O
was	O
designed	O
to	O
enhance	O
delivery	O
in	O
vivo	I:C1515655
.	O

Olumacostat	O
glasaretil	I:C1254351
is	O
a	O
pro-drug	O
of	O
the	O
A	B:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibitor	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
and	O
was	O
designed	O
to	O
enhance	O
delivery	O
in	O
vivo	I:C1515655
.	O

Olumacostat	O
glasaretil	I:C1254351
is	O
a	O
pro-drug	O
of	O
the	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibitor	O
5	B:C0146177
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
and	O
was	O
designed	O
to	O
enhance	O
delivery	O
in	O
vivo	I:C1515655
.	O

Olumacostat	O
glasaretil	I:C1254351
is	O
a	O
pro-drug	O
of	O
the	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibitor	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
and	O
was	O
designed	O
to	O
enhance	O
delivery	O
in	B:C1515655
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	B:C1254351
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	B:C0146177
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	B:C0018557
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	B:C0013443
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	B:C0036505
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	B:C0456389
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	B:C0033262
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	B:C0449445
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	O
vivo	I:C1515655
.	O

Topical	O
application	O
of	O
Olumacostat	O
glasaretil	I:C1254351
but	O
not	O
5	O
-(	I:C0146177
tetradecyloxy	I:C0146177
)	I:C0146177
-	I:C0146177
2-	I:C0146177
furoic	I:C0146177
acid	I:C0146177
significantly	O
reduced	O
hamster	O
ear	O
sebaceous	O
gland	I:C0036505
size	O
,	O
indicating	O
that	O
this	O
pro-drug	O
approach	O
was	O
critical	O
to	O
obtain	O
the	O
desired	O
activity	O
in	B:C1515655
vivo	I:C1515655
.	O

High	B:C1579831
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	B:C0018557
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	B:C0013443
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	B:C1254351
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	B:C0087111
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	B:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	B:C0001026
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	B:C0009226
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	B:C0003062
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	B:C0015684
acid	I:C0015684
oxidation	O
.	O

High	O
-	I:C1579831
performance	I:C1579831
liquid	I:C1579831
chromatography	I:C1579831
analyses	I:C1579831
of	O
hamster	O
ear	O
extracts	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
treatment	O
increased	O
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
levels	O
and	O
the	O
ratio	O
of	O
acetyl	O
-	I:C0001026
CoA	I:C0001026
to	O
free	O
CoA	I:C0009226
in	O
these	O
animals	O
,	O
indicating	O
increased	O
fatty	O
acid	I:C0015684
oxidation	B:C0030011
.	O

These	O
changes	O
are	O
consistent	O
with	O
A	B:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
inhibition	O
.	O

Matrix	B:C0282597
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	B:C0079595
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	B:C1254351
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	B:C0324292
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	B:C0013443
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	B:C0036505
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	O
.	O

Matrix	O
-	I:C0282597
assisted	I:C0282597
laser	I:C0282597
desorption	I:C0282597
/	I:C0282597
ionization	I:C0282597
imaging	O
showed	O
that	O
Olumacostat	O
glasaretil	I:C1254351
applied	O
onto	O
Yorkshire	O
pig	I:C0324292
ears	O
accumulated	O
in	O
sebaceous	O
glands	I:C0036505
relative	O
to	O
the	O
surrounding	O
dermis	B:C0011646
.	O

Sebaceous	B:C0036505
gland	I:C0036505
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
represents	O
an	O
attractive	O
therapeutic	O
target	O
given	O
its	O
central	O
role	O
in	O
formation	O
of	O
sebum	O
,	O
a	O
key	O
factor	O
in	O
acne	O
pathogenesis	O
.	O

Sebaceous	O
gland	I:C0036505
A	B:C0001022
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
represents	O
an	O
attractive	O
therapeutic	O
target	O
given	O
its	O
central	O
role	O
in	O
formation	O
of	O
sebum	O
,	O
a	O
key	O
factor	O
in	O
acne	O
pathogenesis	O
.	O

Sebaceous	O
gland	I:C0036505
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
represents	O
an	O
attractive	O
therapeutic	O
target	O
given	O
its	O
central	O
role	O
in	O
formation	O
of	O
sebum	B:C0036511
,	O
a	O
key	O
factor	O
in	O
acne	O
pathogenesis	O
.	O

Sebaceous	O
gland	I:C0036505
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
represents	O
an	O
attractive	O
therapeutic	O
target	O
given	O
its	O
central	O
role	O
in	O
formation	O
of	O
sebum	O
,	O
a	O
key	O
factor	O
in	O
acne	B:C0702166
pathogenesis	O
.	O

Sebaceous	O
gland	I:C0036505
A	O
(	I:C0001022
CoA	I:C0001022
)	I:C0001022
carboxylase	I:C0001022
represents	O
an	O
attractive	O
therapeutic	O
target	O
given	O
its	O
central	O
role	O
in	O
formation	O
of	O
sebum	O
,	O
a	O
key	O
factor	O
in	O
acne	O
pathogenesis	B:C0699748
.	O

